select trial semaglutide ppt Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design 🔴The STRIDE trial! 👟⤵️ 🔹The

INDICATIONS: Peripheral neuropathy Chronic fatigue syndrome Diabetic neuropathy Cardiovascular support Muscle recovery and fatigue management*

Retatrutide is a triple receptor agonist that activates GLP-1, GIP, and glucagon receptorsthree critical hormonal pathways involved in metabolic regulation

Sherman Oaks: 818-646-2562 Van Nuys: 818-646-4928 Burbank: 818-843-8555 Sherman Oaks: Open Daily | 8am-8pm Van Nuys: Mon, Wed, Thu | 8am5pm Burbank: Open Daily | 8am-8pm Sherman Oaks: 4312 Woodman Ave #102 Sherman Oaks, CA 91423 Van Nuys: 4849 Van Nuys Blvd #100 Sherman Oaks, CA 91403 Burbank: 1701 W Verdugo Ave Burbank, CA 91506

Cigna said it would continue supporting workers through weight-management programs and other resources, but the core decision is clear enough: the company no longer wants its plan paying for GLP-1s when they are prescribed for weight loss

Exercise did not improve any aspect of metabolic syndrome in #schizophrenia in new analysis of 10 trials: Check weight before and 1-mth after antipsychotic If 5% gain, start metformin or change med Consider GLP-1 if BMI 30 Supplements: Probiotics and melatonin (3-5 mg) for weight, omega-3's for lipids: Anyone have other ideas

Clear aftercare that protects your progress: The days after treatment matter, gentle skincare and daily SPF help support healing and keep results on track